Publisher
Springer International Publishing
Reference19 articles.
1. Marketing Clearance of Diagnostic Ultrasound Systems and Transducers Guidance for Industry and Food and Drug Administration Staff. Document issued on: June 27, 2019.
https://www.fda.gov/media/71100/download
. Accessed 1 Nov 2019.
2. Bioeffects Committee of the American Institute of Ultrasound in Medicine. American Institute of Ultrasound in Medicine consensus report on potential bioeffects of diagnostic ultrasound: executive summary. J Ultrasound Med. 2008;27:503–15.
3. Bass R, Fleshner N, Finelli A, Barkin J, Zhang L, Klotz L, Klotz L. Oncologic and functional outcomes of partial gland ablation with high intensity focused ultrasound for localized prostate cancer. J Urol. 2019;201:113–9.
4. Rumack CM, Wilson SR, Charboneau JW. Diagnostic ultrasound, Chap. 2. 3rd ed. St. Louis: Mosby; 2005. p. 37.
5. O’Brien WD, Deng CS, Harris GR, Herman BA, Merritt CR, Sanghvi N, et al. The risk of exposure to diagnostic ultrasound in postnatal subjects: thermal effects. J Ultrasound Med. 2008;27:517–35.